Most Popular Articles

Monoclonal antibodies with equal specificity to D-dimer and high-molecular-weight fibrin degradation products

Kogan, Alexander E.; Mukharyamova, Kadriya S.; Bereznikova, Anastasia V.; More

Blood Coagulation & Fibrinolysis. 27(5):542-550, July 2016.

Pharmacokinetics, efficacy, and safety of a plasma-derived VWF/FVIII concentrate (VONCENTO) for on-demand and prophylactic treatment in patients with von Willebrand disease (SWIFT-VWD study)

Lissitchkov, Toshko J.; Buevich, Evgeny; Kuliczkowski, Kazimierz; More

Blood Coagulation & Fibrinolysis. 28(2):152-162, March 2017.

Physical activity in individuals with haemophilia and experience with recombinant factor VIII Fc fusion protein and recombinant factor IX Fc fusion protein for the treatment of active patients: a literature review and case reports

Wang, Michael; Álvarez-Román, María Teresa; Chowdary, Pratima; More

Blood Coagulation & Fibrinolysis. 27(7):737-744, October 2016.

Home treatment of haemarthrosis with recombinant activated factor VII in patients with haemophilia A or B and inhibitors: experience from developing countries

Bensadok, Meriem; Almomen, Abdulkareem; Alzoebie, Azzam; More

Blood Coagulation & Fibrinolysis. 28(2):145-151, March 2017.

Lack of grading agreement among international hemostasis external quality assessment programs

Olson, John D.; Jennings, Ian; Meijer, Piet; More

Blood Coagulation & Fibrinolysis. 29(1):111-119, January 2018.

Validation of STA-Liatest D-Di assay for exclusion of pulmonary embolism according to the latest Clinical and Laboratory Standard Institute/Food and Drug Administration guideline. Results of a multicenter management study

Pernod, Gilles; Wu, Haifeng; de Maistre, Emmanuel; More

Blood Coagulation & Fibrinolysis. 28(3):254-260, April 2017.

Correcting thrombin generation ex vivo using different haemostatic agents following cardiac surgery requiring the use of cardiopulmonary bypass

Percy, Charles L.; Hartmann, Rudolf; Jones, Rhidian M.; More

Blood Coagulation & Fibrinolysis. 26(4):357-367, June 2015.

Use of recombinant activated factor VII for acute bleeding episodes in acquired hemophilia: final analysis from the Hemostasis and Thrombosis Research Society Registry acquired hemophilia study

Ma, Alice D.; Kessler, Craig M.; Al-Mondhiry, Hamid A.B.; More

Blood Coagulation & Fibrinolysis. 27(7):753-760, October 2016.

Global Post-Authorization Safety Surveillance Study: real-world data on prophylaxis and on-demand treatment using FEIBA (an activated prothrombin complex concentrate)

Negrier, Claude; Voisin, Sophie; Baghaei, Fariba; More

Blood Coagulation & Fibrinolysis. 27(5):551-556, July 2016.

Treatment characteristics, efficacy and safety of thrombopoietin analogues in routine management of primary immune thrombocytopenia

Mingot-Castellano, María E.; Caparrós, Isabel S.; Fernández, Fernando; More

Blood Coagulation & Fibrinolysis. 29(4):374-380, June 2018.

Show: